Clinical applications for diffusion magnetic resonance imaging in radiotherapy.
暂无分享,去创建一个
[1] P. Brown,et al. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] A. A. Abdel Razek,et al. Role of diffusion-weighted MR imaging in cervical lymphadenopathy , 2006, European Radiology.
[3] D. Yousem,et al. ADC values and prognosis of malignant astrocytomas: does lower ADC predict a worse prognosis independent of grade of tumor?--a meta-analysis. , 2013, AJR. American journal of roentgenology.
[4] J. Gore,et al. Theoretical Model for Water Diffusion in Tissues , 1995, Magnetic resonance in medicine.
[5] T. Chenevert,et al. Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck. , 2008, Translational oncology.
[6] B. K. Park,et al. Prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience , 2010, Abdominal Imaging.
[7] Yue Cao,et al. Radiation-induced changes in normal-appearing white matter in patients with cerebral tumors: a diffusion tensor imaging study. , 2008, International journal of radiation oncology, biology, physics.
[8] Chaya S Moskowitz,et al. Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy? , 2013, Radiology.
[9] E. M. Pedersen,et al. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer , 2010, Acta oncologica.
[10] J. M. Taylor,et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. , 2000, Journal of the National Cancer Institute.
[11] Yue Cao,et al. Investigation of the diffusion abnormality index as a new imaging biomarker for early assessment of brain tumor response to radiation therapy. , 2014, Neuro-oncology.
[12] Chuan-miao Xie,et al. Diffusion-Weighted Magnetic Resonance Imaging for Prediction of Response of Advanced Cervical Cancer to Chemoradiation , 2011, Journal of computer assisted tomography.
[13] Bradford A Moffat,et al. Therapeutic Efficacy of DTI-015 using Diffusion Magnetic Resonance Imaging as an Early Surrogate Marker , 2004, Clinical Cancer Research.
[14] Thomas L. Chenevert. Principles of Diffusion-Weighted Imaging (DW-MRI) as Applied to Body Imaging , 2010 .
[15] J G Pipe,et al. Effect of bulk tissue motion on quantitative perfusion and diffusion magnetic resonance imaging , 1991, Magnetic resonance in medicine.
[16] T L Chenevert,et al. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[17] A. Peiffer,et al. Imaging Radiation-Induced Normal Tissue Injury , 2012, Radiation research.
[18] Ernst J Rummeny,et al. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. , 2009, European journal of radiology.
[19] Sandra Nuyts,et al. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. , 2009, Radiology.
[20] Risto A Kauppinen,et al. Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy , 2002, NMR in biomedicine.
[21] D. Norris. Implications of bulk motion for diffusion‐weighted imaging experiments: Effects, mechanisms, and solutions , 2001, Journal of magnetic resonance imaging : JMRI.
[22] P. Narayana,et al. Serial diffusion tensor imaging to characterize radiation-induced changes in normal-appearing white matter following radiotherapy in patients with adult low-grade gliomas , 2008, Radiation Medicine.
[23] C. Kim,et al. Prediction of locally recurrent prostate cancer after radiation therapy: Incremental value of 3T diffusion‐weighted MRI , 2009, Journal of magnetic resonance imaging : JMRI.
[24] Zhibin Huang,et al. Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer. , 2010, International journal of radiation oncology, biology, physics.
[25] Jian Z. Wang,et al. Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model. , 2012, International Journal of Radiation Oncology, Biology, Physics.
[26] D. Norris. The effects of microscopic tissue parameters on the diffusion weighted magnetic resonance imaging experiment , 2001, NMR in biomedicine.
[27] Fiona J. Gilbert,et al. Early diffusion weighted magnetic resonance imaging can predict survival in women with locally advanced cancer of the cervix treated with combined chemo-radiation , 2012, European Radiology.
[28] Bradford A Moffat,et al. A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. , 2009, Translational oncology.
[29] Bradford A Moffat,et al. Evaluation of cancer therapy using diffusion magnetic resonance imaging. , 2003, Molecular cancer therapeutics.
[30] C. Pelizzari,et al. Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging. , 2013, International journal of radiation oncology, biology, physics.
[31] Shiro Baba,et al. Diffusion-weighted imaging of local recurrent prostate cancer after radiation therapy: comparison with 22-core three-dimensional prostate mapping biopsy. , 2012, Magnetic resonance imaging.
[32] Timothy D Johnson,et al. Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] C. Meyer,et al. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[34] P. Grigsby,et al. Tumor volume and subvolume concordance between FDG‐PET/CT and diffusion‐weighted MRI for squamous cell carcinoma of the cervix , 2013, Journal of magnetic resonance imaging : JMRI.
[35] D. Le Bihan,et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. , 1988, Radiology.
[36] Bradford A Moffat,et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[37] Jacob Sosna,et al. MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla. , 2004, Academic radiology.
[38] Takeo Ishigaki,et al. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. , 2007, European journal of radiology.
[39] Tobias Fechter,et al. 3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer – an interobserver variability study , 2013, Radiation oncology.
[40] Timothy D Johnson,et al. Comparison of apparent diffusion coefficients and distributed diffusion coefficients in high‐grade gliomas , 2010, Journal of magnetic resonance imaging : JMRI.
[41] Timothy D Johnson,et al. The parametric response map is an imaging biomarker for early cancer treatment outcome , 2009, Nature Medicine.
[42] Daniel E. Hall,et al. Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy. , 2002, Molecular imaging.
[43] H. Buchtel,et al. Diffusion tensor imaging of normal-appearing white matter as biomarker for radiation-induced late delayed cognitive decline. , 2012, International journal of radiation oncology, biology, physics.
[44] Lawrence H. Schwartz,et al. Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results , 2011, European Radiology.
[45] Aytekin Oto,et al. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. , 2010, Radiology.
[46] Toshinori Hirai,et al. Usefulness of diffusion-weighted imaging in the localization of prostate cancer. , 2009, International journal of radiation oncology, biology, physics.
[47] H. Lanfermann,et al. Cerebral gliomas: diffusional kurtosis imaging analysis of microstructural differences. , 2010, Radiology.
[48] Jason A Koutcher,et al. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. , 2009, Radiology.
[49] David A Jaffray,et al. Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer , 2013, Journal of magnetic resonance imaging : JMRI.
[50] F. Gilbert,et al. Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. , 2008, Gynecologic oncology.
[51] Timothy D Johnson,et al. Prospective Analysis of Parametric Response Map–Derived MRI Biomarkers: Identification of Early and Distinct Glioma Response Patterns Not Predicted by Standard Radiographic Assessment , 2011, Clinical Cancer Research.
[52] P. Grenier,et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. , 1986, Radiology.
[53] F. Mottaghy,et al. Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules? , 2012, International journal of radiation oncology, biology, physics.
[54] Masoom A. Haider,et al. Diffusion-weighted MRI in cervical cancer , 2008, European Radiology.
[55] Jan Sijbers,et al. Gliomas: diffusion kurtosis MR imaging in grading. , 2012, Radiology.
[56] D. Moody,et al. Vascular Damage after Fractionated Whole-Brain Irradiation in Rats , 2005, Radiation research.
[57] Toshinori Hirai,et al. Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas , 1999, Journal of magnetic resonance imaging : JMRI.